Literature DB >> 12657431

Modeling gene-environment interactions in malignant melanoma.

Glenn Merlino1, Frances P Noonan.   

Abstract

Many cancers are the pathological consequence of environmentally initiated disruptions to cellular genetic control mechanisms. For most cancers the relevant environmental carcinogens have not been identified, but one major exception is cutaneous malignant melanoma, for which the primary environmental agent is solar ultraviolet (UV) radiation. Hence, melanomagenesis represents a potential model of detrimental gene-environment interaction. Although the underlying genetic basis of melanoma is currently being elucidated, fundamental questions concerning UV and the mechanisms by which it operates remain unanswered. Significant progress has recently been made in creating UV-responsive, genetically tractable mouse models of melanoma that accurately recapitulate human disease. These models are providing novel insights into how the genome and environment interact in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657431     DOI: 10.1016/s1471-4914(03)00006-6

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  7 in total

1.  Identifying gene-environment interactions incorporating prior information.

Authors:  Xiaoyan Wang; Yonghong Xu; Shuangge Ma
Journal:  Stat Med       Date:  2019-01-13       Impact factor: 2.373

Review 2.  Tumour predisposition and cancer syndromes as models to study gene-environment interactions.

Authors:  Michele Carbone; Sarah T Arron; Bruce Beutler; Angela Bononi; Webster Cavenee; James E Cleaver; Carlo M Croce; Alan D'Andrea; William D Foulkes; Giovanni Gaudino; Joanna L Groden; Elizabeth P Henske; Ian D Hickson; Paul M Hwang; Richard D Kolodner; Tak W Mak; David Malkin; Raymond J Monnat; Flavia Novelli; Harvey I Pass; John H Petrini; Laura S Schmidt; Haining Yang
Journal:  Nat Rev Cancer       Date:  2020-05-29       Impact factor: 60.716

3.  UVB-induced gene expression in the skin of Xiphophorus maculatus Jp 163 B.

Authors:  Kuan Yang; Mikki Boswell; Dylan J Walter; Kevin P Downs; Kimberly Gaston-Pravia; Tzintzuni Garcia; Yingjia Shen; David L Mitchell; Ronald B Walter
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2014-02-17       Impact factor: 3.228

Review 4.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

5.  Notch1 is an effector of Akt and hypoxia in melanoma development.

Authors:  Barbara Bedogni; James A Warneke; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

6.  Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets.

Authors:  Eumorphia G Konstantakou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Zoi I Litou; Ourania A Konstandi; Aikaterini F Giannopoulou; Ema Anastasiadou; Gerassimos E Voutsinas; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

7.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.